| Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis (NCT02079649) | Alcon Research | 2014-04-01 |
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial (NCT02111161) | Anders Perner | 2014-04-01 |
| Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy (NCT02116348) | Ain Shams University | 2014-04-01 |
| Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NCT02106520) | Hospices Civils de Lyon | 2014-04-01 |
| Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (NCT02095743) | Centre Henri Becquerel | 2014-04-01 |
| Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency (NCT02019667) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-03-31 |
| Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection (NCT04170595) | Genor Biopharma Co., Ltd. | 2014-03-28 |
| Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT02095132) | National Cancer Institute (NCI) | 2014-03-28 |
| Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT03281083) | Duke-NUS Graduate Medical School | 2014-03-28 |
| Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers (NCT03003065) | Chinese University of Hong Kong | 2014-03-28 |
| Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NCT02038907) | Takeda | 2014-03-28 |
| Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) (NCT02085018) | Newcastle-upon-Tyne Hospitals NHS Trust | 2014-03-28 |
| Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) (NCT02076178) | ViiV Healthcare | 2014-03-27 |
| Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer (NCT02045433) | University of Texas Southwestern Medical Center | 2014-03-27 |
| Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) (NCT01954979) | Beth Israel Deaconess Medical Center | 2014-03-27 |
| Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia (NCT02096510) | Haukeland University Hospital | 2014-03-27 |
| Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201 (NCT02075008) | Novartis Pharmaceuticals | 2014-03-27 |
| Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa (NCT02090283) | Scioderm, Inc. | 2014-03-26 |
| A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone (NCT02066389) | AbbVie | 2014-03-26 |
| Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02079740) | National Cancer Institute (NCI) | 2014-03-26 |
| Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis (NCT02124070) | National Human Genome Research Institute (NHGRI) | 2014-03-26 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (NCT02083185) | Millennium Pharmaceuticals, Inc. | 2014-03-26 |
| Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) (NCT02038946) | Bristol-Myers Squibb | 2014-03-26 |
| A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia (NCT02008773) | Indiana University | 2014-03-26 |
| Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer (NCT02047474) | Yale University | 2014-03-25 |
| In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis (NCT01927120) | H. Lee Moffitt Cancer Center and Research Institute | 2014-03-25 |
| Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome (NCT02094352) | Hospital for Special Surgery, New York | 2014-03-24 |
| Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections (NCT02045797) | GlaxoSmithKline | 2014-03-24 |
| Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (NCT02048865) | Ottawa Hospital Research Institute | 2014-03-24 |
| Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment (NCT02055118) | Shire | 2014-03-24 |
| Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma (NCT01989585) | National Cancer Institute (NCI) | 2014-03-24 |
| Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (NCT02052739) | Supernus Pharmaceuticals, Inc. | 2014-03-21 |
| Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C (NCT02118012) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-03-20 |
| Everolimus With and Without Temozolomide in Adult Low Grade Glioma (NCT02023905) | University of California, San Francisco | 2014-03-19 |
| A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women (NCT02100540) | Yung Shin Pharm. Ind. Co., Ltd. | 2014-03-19 |
| Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis (NCT02168816) | Loyola University | 2014-03-19 |
| Angiography Study of BioNIR Drug Eluting Stent System (NIREUS) (NCT01995500) | Medinol Ltd. | 2014-03-19 |
| Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma (NCT01969435) | Washington University School of Medicine | 2014-03-19 |
| Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (NCT01999868) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-19 |
| Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma (NCT02083354) | Novartis Pharmaceuticals | 2014-03-18 |
| Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women (NCT02046148) | GlaxoSmithKline | 2014-03-18 |
| A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) (NCT02057913) | Institute of Cancer Research, United Kingdom | 2014-03-17 |
| Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) (NCT02092350) | Merck Sharp & Dohme LLC | 2014-03-17 |
| Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer (NCT02065687) | Gynecologic Oncology Group | 2014-03-17 |
| Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29) (NCT02089685) | Merck Sharp & Dohme LLC | 2014-03-17 |
| Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) (NCT02097641) | Michael A. Matthay | 2014-03-15 |
| Regorafenib Versus Placebo to Treat Cholangiocarcinoma (NCT02162914) | Erasme University Hospital | 2014-03-14 |
| A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis (NCT02133404) | Astellas Pharma Inc | 2014-03-14 |
| Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia (NCT02088632) | Thomas Jefferson University | 2014-03-14 |
| Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome (NCT02101138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-14 |
| Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study (NCT01843101) | Medical University of Vienna | 2014-03-14 |
| Renal Nerves Stimulation Study (NCT02496117) | Diagram B.V. | 2014-03-14 |
| Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT02077166) | Pharmacyclics LLC. | 2014-03-13 |
| Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 (NCT02064426) | Bayer | 2014-03-13 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies (NCT02061761) | Bristol-Myers Squibb | 2014-03-13 |
| Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients (NCT02000817) | GlaxoSmithKline | 2014-03-12 |
| A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread (NCT02060188) | Bristol-Myers Squibb | 2014-03-12 |
| Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers (NCT02034110) | Novartis Pharmaceuticals | 2014-03-12 |
| Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis (NCT02250443) | Novartis Pharmaceuticals | 2014-03-11 |
| Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen. (NCT02033993) | Canadian Cancer Trials Group | 2014-03-11 |
| Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women (NCT01923168) | Novartis Pharmaceuticals | 2014-03-11 |
| Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis (NCT02039401) | Helixmith Co., Ltd. | 2014-03-11 |
| Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions (NCT02086578) | Memorial Sloan Kettering Cancer Center | 2014-03-11 |
| A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma (NCT02078102) | Sherif S. Farag | 2014-03-11 |
| Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults (NCT02052154) | Assistance Publique - Hôpitaux de Paris | 2014-03-10 |
| Comparative PK PD Study in PAH Patients (Fox vs. I-Neb) (NCT02032836) | Bayer | 2014-03-10 |
| Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone (NCT02023697) | Bayer | 2014-03-10 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus (NCT01899703) | GlaxoSmithKline | 2014-03-10 |
| Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients (NCT02159365) | Bristol-Myers Squibb | 2014-03-08 |
| Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01896999) | National Cancer Institute (NCI) | 2014-03-07 |
| Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk (NCT02028221) | University of Arizona | 2014-03-07 |
| A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) (NCT02034552) | Bayer | 2014-03-07 |
| LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib (NCT02040870) | Novartis Pharmaceuticals | 2014-03-07 |
| A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer (NCT02082210) | Eli Lilly and Company | 2014-03-07 |
| Depression Treatment and Risk for Cardiovascular Disease (NCT06170255) | East Carolina University | 2014-03-06 |
| Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer (NCT02083653) | Symphogen A/S | 2014-03-06 |
| Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease (NCT01915303) | Novartis Pharmaceuticals | 2014-03-06 |
| Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD (NCT02027805) | Xenikos | 2014-03-05 |
| Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) (NCT02038933) | Bristol-Myers Squibb | 2014-03-05 |
| Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma (NCT02046070) | Millennium Pharmaceuticals, Inc. | 2014-03-05 |
| Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01946152) | M.D. Anderson Cancer Center | 2014-03-05 |
| A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention (NCT02066415) | Amgen | 2014-03-05 |
| A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy (NCT01789879) | University of Nebraska | 2014-03-04 |
| A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone (NCT01288573) | Genzyme, a Sanofi Company | 2014-03-03 |
| Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas (NCT01986348) | Karyopharm Therapeutics Inc | 2014-03-03 |
| AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery (NCT02065245) | Longeveron Inc. | 2014-03-03 |
| Versartis Long-Term Safety Study of Somavaratan (NCT02068521) | Versartis Inc. | 2014-03-03 |
| Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction (NCT01825122) | Invion, Inc. | 2014-03-01 |
| Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine (NCT02095314) | PT Bio Farma | 2014-03-01 |
| Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects (NCT02055976) | Pfizer | 2014-03-01 |
| Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma (NCT02075021) | NYU Langone Health | 2014-03-01 |
| A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults (NCT02079168) | RXi Pharmaceuticals, Corp. | 2014-03-01 |
| Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT) (NCT02118415) | Technical University of Munich | 2014-03-01 |
| A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors (NCT02279758) | Instituto do Cancer do Estado de São Paulo | 2014-03-01 |
| Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC (NCT02200081) | Mologen AG | 2014-03-01 |
| Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis (NCT02048644) | Hull University Teaching Hospitals NHS Trust | 2014-03-01 |
| A Study of Galunisertib in Participants With Myelodysplastic Syndromes (NCT02008318) | Eli Lilly and Company | 2014-03-01 |
| A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer (NCT02087176) | AstraZeneca | 2014-03-01 |
| Guanfacine Clinical Trial for Smoking Cessation (NCT02051309) | Yale University | 2014-03-01 |
| The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease (NCT02260960) | Physician Recommended Nutriceuticals | 2014-03-01 |